Two Top Stories of NYSE: BioPharmX Corporation (NYSE:BPMX), Daxor Corp. (NYSE:DXR)

BioPharmX Corporation (NYSE:BPMX)

The shares of BioPharmX Corporation (NYSE:BPMX) started off the last trading session with the price of $0.29 while closing the day with the price of $0.29. The shares of BioPharmX Corporation (NYSE:BPMX) Fell -2.36% with the Gain of 0 points.

The shares of BioPharmX Corporation (NYSE:BPMX) traded with the day volume of 18.63 Million shares whereas its average trading volume is 13.89 Million.

While analyzing the past performance of the stock we can see that the shares of BioPharmX Corporation (NYSE:BPMX) Loss -3.97% in the last week while rising 72.31% in the last month. Past quarter performance shows the green light with 155.51%. The semi-annual and annual performance shows -3.33% and -46.3% respectively.

Some critical values of the shares of BioPharmX Corporation (NYSE:BPMX) to be discussed here are: the beta which shows the value at -0.7 while Average True Range of BioPharmX Corporation (NYSE:BPMX) demonstrate the value at 0.04. The weekly and monthly volatility of the shares of BioPharmX Corporation (NYSE:BPMX) are indicated at 14.29% and 15.41%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 60.43.

While studying the financial position of the shares of BioPharmX Corporation (NYSE:BPMX), we can see that the Market capitalization of the company is at 34.04 Million. The shares outstanding for the company is 117.38 Million and the shares float stands at 117.38 Million. The income of the company stand at -18000000 while the sales stand at 70000.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at -0.27, Price to Earnings or P/E is at 0, Price to Sales P/S show the value of 493.34, the Return on Asset ROA stood at -3.269 and the Return on Equity ROE depicted at 0 while Return on Investment ROI is at 0.


Daxor Corp. (NYSE:DXR)

Daxor Corp. (NYSE:DXR) started its previous trading session at $8.25 and closed at $13.35 showing a Rise of 71.16 Percent.

The Company traded with an average Volume of 134.14 Million whereas, its Day Volume stood at 18.56 Million.

Looking at the performance of the stock, Daxor Corp. (NYSE:DXR) Gain 103.82% in the last week in its shares price and 242.31% in the last month. Quarterly performance shows a green of 142.73 Percent while Semi-Annual and Annual performances shows a 127.04 and 69.5 percent respectively.

Beta for Daxor Corp. (NYSE:DXR) stands at 0.37 while the ATR (average true range) is at 1.74. The Stock’s Weekly and Monthly Volatility is 62.03% and 20.99% respectively showing a RSI value of 85.63.

While studying the financial position of the shares of Daxor Corp. (NYSE:DXR), we can see that the Market capitalization of the company is at 55.14 Million. The shares outstanding for the company is 4.13 Million and the shares float stands at 740000.

The Company generated an income of -800000 and the sales of 500000 in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-0.21 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 110.27 respectively.

The Return on Assets stands at -0.038, ROE shows a value of -0.052 and ROI for Daxor Corp. (NYSE:DXR) is 0.006 as of Trailing Twelve Months period.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

    Leave a Comment